COMBINATION THERAPIES COMPRISING GDC-6036 AND GDC-0077 FOR THE TREATMENT OF CANCER

Provided herein are combination therapies comprising a KRasG12C inhibitor (e.g. GDC-6036) and an PI3K-inhibitor (e.g. inavolisib) and methods of using such combination therapies. L'invention concerne des polythérapies faisant intervenir un inhibiteur de KRasG12C (par exemple GDC-6036) et un inh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JOO, Stephanie Royer, SONG, Chunyan, SCHUTZMAN, Jennifer Lee, SHI, Zhen, MERCHANT, Mark Andrew, DHARIA, Neekesh Vijay
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided herein are combination therapies comprising a KRasG12C inhibitor (e.g. GDC-6036) and an PI3K-inhibitor (e.g. inavolisib) and methods of using such combination therapies. L'invention concerne des polythérapies faisant intervenir un inhibiteur de KRasG12C (par exemple GDC-6036) et un inhibiteur de PI3K (par exemple, inavolisib) et des méthodes d'utilisation desdites polythérapies.